BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 17699803)

  • 1. Atorvastatin but not elocalcitol increases sildenafil responsiveness in spontaneously hypertensive rats by regulating the RhoA/ROCK pathway.
    Fibbi B; Morelli A; Marini M; Zhang XH; Mancina R; Vignozzi L; Filippi S; Chavalmane A; Silvestrini E; Colli E; Adorini L; Vannelli GB; Maggi M
    J Androl; 2008; 29(1):70-84. PubMed ID: 17699803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atorvastatin ameliorates sildenafil-induced penile erections in experimental diabetes by inhibiting diabetes-induced RhoA/Rho-kinase signaling hyperactivation.
    Morelli A; Chavalmane AK; Filippi S; Fibbi B; Silvestrini E; Sarchielli E; Zhang XH; Vignozzi L; Vannelli GB; Forti G; Maggi M
    J Sex Med; 2009 Jan; 6(1):91-106. PubMed ID: 19170840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BXL-628, a vitamin D receptor agonist effective in benign prostatic hyperplasia treatment, prevents RhoA activation and inhibits RhoA/Rho kinase signaling in rat and human bladder.
    Morelli A; Vignozzi L; Filippi S; Vannelli GB; Ambrosini S; Mancina R; Crescioli C; Donati S; Fibbi B; Colli E; Adorini L; Maggi M
    Prostate; 2007 Feb; 67(3):234-47. PubMed ID: 17163492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 2-methoxyestradiol inhibits atorvastatin-induced rounding of human vascular smooth muscle cells.
    Yin H; Gui Y; Zheng XL
    J Cell Physiol; 2010 Mar; 222(3):556-64. PubMed ID: 19937728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of quinapril and atorvastatin on artery structure and function in adult spontaneously hypertensive rats.
    Yang L; Gao YJ; Lee RM
    Eur J Pharmacol; 2005 Aug; 518(2-3):145-51. PubMed ID: 16024013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The vitamin D receptor agonist elocalcitol inhibits IL-8-dependent benign prostatic hyperplasia stromal cell proliferation and inflammatory response by targeting the RhoA/Rho kinase and NF-kappaB pathways.
    Penna G; Fibbi B; Amuchastegui S; Corsiero E; Laverny G; Silvestrini E; Chavalmane A; Morelli A; Sarchielli E; Vannelli GB; Gacci M; Colli E; Maggi M; Adorini L
    Prostate; 2009 Apr; 69(5):480-93. PubMed ID: 19107880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rho-kinase inhibition suppresses bladder hyperactivity in spontaneously hypertensive rats.
    Rajasekaran M; Wilkes N; Kuntz S; E Albo M
    Neurourol Urodyn; 2005; 24(3):295-300. PubMed ID: 15791631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of PDE5 inhibition combined with free oxygen radical scavenger therapy on erectile function in a diabetic animal model.
    De Young L; Yu D; Freeman D; Brock GB
    Int J Impot Res; 2003 Oct; 15(5):347-54. PubMed ID: 14562136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statins normalize vascular lysyl oxidase down-regulation induced by proatherogenic risk factors.
    Rodríguez C; Alcudia JF; Martínez-González J; Guadall A; Raposo B; Sánchez-Gómez S; Badimon L
    Cardiovasc Res; 2009 Aug; 83(3):595-603. PubMed ID: 19406911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vardenafil modulates bladder contractility through cGMP-mediated inhibition of RhoA/Rho kinase signaling pathway in spontaneously hypertensive rats.
    Morelli A; Filippi S; Sandner P; Fibbi B; Chavalmane AK; Silvestrini E; Sarchielli E; Vignozzi L; Gacci M; Carini M; Vannelli GB; Maggi M
    J Sex Med; 2009 Jun; 6(6):1594-1608. PubMed ID: 19473460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atorvastatin inhibits myocardin expression in vascular smooth muscle cells.
    Li J; Jiang J; Yin H; Wang L; Tian R; Li H; Wang Z; Li D; Wang Y; Gui Y; Walsh MP; Zheng XL
    Hypertension; 2012 Jul; 60(1):145-53. PubMed ID: 22615115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atorvastatin lowers portal pressure in cirrhotic rats by inhibition of RhoA/Rho-kinase and activation of endothelial nitric oxide synthase.
    Trebicka J; Hennenberg M; Laleman W; Shelest N; Biecker E; Schepke M; Nevens F; Sauerbruch T; Heller J
    Hepatology; 2007 Jul; 46(1):242-53. PubMed ID: 17596891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue-specific effects of atorvastatin on 3-hydroxy-3-methylglutarylcoenzyme A reductase expression and activity in spontaneously hypertensive rats.
    Chen GP; Yao L; Lu X; Li L; Hu SJ
    Acta Pharmacol Sin; 2008 Oct; 29(10):1181-6. PubMed ID: 18817622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sildenafil prevents change in RhoA expression induced by chronic hypoxia in rat pulmonary artery.
    Sauzeau V; Rolli-Derkinderen M; Lehoux S; Loirand G; Pacaud P
    Circ Res; 2003 Oct; 93(7):630-7. PubMed ID: 12946946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beneficial effect of atorvastatin on left ventricular remodeling in spontaneously hypertensive rats.
    Kang L; Ge CJ; Hu SJ
    Pharmacology; 2007; 80(2-3):120-6. PubMed ID: 17534121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphodiesterase-5 inhibition synergizes rho-kinase antagonism and enhances erectile response in male hypertensive rats.
    Wilkes N; White S; Stein P; Bernie J; Rajasekaran M
    Int J Impot Res; 2004 Apr; 16(2):187-94. PubMed ID: 15073608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atorvastatin enhances sildenafil-induced vasodilation through nitric oxide-mediated mechanisms.
    Castro MM; Rizzi E; Rascado RR; Nagassaki S; Bendhack LM; Tanus-Santos JE
    Eur J Pharmacol; 2004 Sep; 498(1-3):189-94. PubMed ID: 15363994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atorvastatin prevents connexin43 remodeling in hypertrophied left ventricular myocardium of spontaneously hypertensive rats.
    Chen HJ; Yao L; Chen TG; Yu M; Wang LH; Chen JZ
    Chin Med J (Engl); 2007 Nov; 120(21):1902-7. PubMed ID: 18067764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of combination endothelial nitric oxide synthase gene therapy and sildenafil on erectile function in diabetic rats.
    Bivalacqua TJ; Usta MF; Champion HC; Leungwattanakij S; Dabisch PA; McNamara DB; Kadowitz PJ; Hellstrom WJ
    Int J Impot Res; 2004 Feb; 16(1):21-9. PubMed ID: 14963467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activated RhoA/Rho kinase impairs erectile function after cavernous nerve injury in rats.
    Gratzke C; Strong TD; Gebska MA; Champion HC; Stief CG; Burnett AL; Bivalacqua TJ
    J Urol; 2010 Nov; 184(5):2197-204. PubMed ID: 20851436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.